NCT00042250View on ClinicalTrials.gov

IUdR/BUdR Cell Cycle Labelling

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 1992

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Hematologic Malignancies
Interventions
DRUG

Chemotherapy for hematologic malignancy

Trial Locations (1)

77030

M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00042250 - IUdR/BUdR Cell Cycle Labelling | Biotech Hunter | Biotech Hunter